77 related articles for article (PubMed ID: 21740106)
1. A screening assay for neuraminidase inhibitors using neuraminidases N1 and N3 from a baculovirus expression system.
Kongkamnerd J; Milani A; Cattoli G; Terregino C; Capua I; Beneduce L; Gallotta A; Pengo P; Fassina G; Miertus S; De-Eknamkul W
J Enzyme Inhib Med Chem; 2012 Feb; 27(1):5-11. PubMed ID: 21740106
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro study of novel neuraminidase inhibitors against avian influenza virus.
Kongkamnerd J; Cappelletti L; Prandi A; Seneci P; Rungrotmongkol T; Jongaroonngamsang N; Rojsitthisak P; Frecer V; Milani A; Cattoli G; Terregino C; Capua I; Beneduce L; Gallotta A; Pengo P; Fassina G; Miertus S; De-Eknamkul W
Bioorg Med Chem; 2012 Mar; 20(6):2152-7. PubMed ID: 22342267
[TBL] [Abstract][Full Text] [Related]
3. Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
Rungrotmongkol T; Frecer V; De-Eknamkul W; Hannongbua S; Miertus S
Antiviral Res; 2009 Apr; 82(1):51-8. PubMed ID: 19428595
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes.
Albohy A; Mohan S; Zheng RB; Pinto BM; Cairo CW
Bioorg Med Chem; 2011 May; 19(9):2817-22. PubMed ID: 21489803
[TBL] [Abstract][Full Text] [Related]
5. Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.
Abed Y; Nehmé B; Baz M; Boivin G
Antiviral Res; 2008 Feb; 77(2):163-6. PubMed ID: 17919743
[TBL] [Abstract][Full Text] [Related]
6. DNA-linked inhibitor antibody assay (DIANA) as a new method for screening influenza neuraminidase inhibitors.
Kožíšek M; Navrátil V; Rojíková K; Pokorná J; Berenguer Albiñana C; Pachl P; Zemanová J; Machara A; Šácha P; Hudlický J; Císařová I; Řezáčová P; Konvalinka J
Biochem J; 2018 Dec; 475(23):3847-3860. PubMed ID: 30404922
[TBL] [Abstract][Full Text] [Related]
7. Galactose-conjugates of the oseltamivir pharmacophore--new tools for the characterization of influenza virus neuraminidases.
Carbain B; Martin SR; Collins PJ; Hitchcock PB; Streicher H
Org Biomol Chem; 2009 Jun; 7(12):2570-5. PubMed ID: 19503932
[TBL] [Abstract][Full Text] [Related]
8. [A study on the standard of influenza neuraminidase inhibition assay].
Yang F; Liu AL; Du GH
Yao Xue Xue Bao; 2012 Jun; 47(6):730-3. PubMed ID: 22919719
[TBL] [Abstract][Full Text] [Related]
9. Computational design of novel, high-affinity neuraminidase inhibitors for H5N1 avian influenza virus.
Park JW; Jo WH
Eur J Med Chem; 2010 Feb; 45(2):536-41. PubMed ID: 19914748
[TBL] [Abstract][Full Text] [Related]
10. Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles.
Mohan S; McAtamney S; Haselhorst T; von Itzstein M; Pinto BM
J Med Chem; 2010 Oct; 53(20):7377-91. PubMed ID: 20873795
[TBL] [Abstract][Full Text] [Related]
11. Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)".
Rungrotmongkol T; Malaisree M; Udommaneethanakit T; Hannongbua S
Biophys Chem; 2009 Apr; 141(1):131-2; author reply 133. PubMed ID: 19231807
[No Abstract] [Full Text] [Related]
12. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
Du QS; Wang SQ; Chou KC
Biochem Biophys Res Commun; 2007 Oct; 362(2):525-31. PubMed ID: 17707775
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of viral group-1 and group-2 neuraminidases by oseltamivir: A comparative structural analysis by the ScrewFit algorithm.
Calligari PA; Kneller GR; Giansanti A; Ascenzi P; Porrello A; Bocedi A
Biophys Chem; 2009 Apr; 141(1):117-23. PubMed ID: 19195766
[TBL] [Abstract][Full Text] [Related]
14. Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro.
Zürcher T; Yates PJ; Daly J; Sahasrabudhe A; Walters M; Dash L; Tisdale M; McKimm-Breschkin JL
J Antimicrob Chemother; 2006 Oct; 58(4):723-32. PubMed ID: 16891631
[TBL] [Abstract][Full Text] [Related]
15. Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses.
Dao TT; Dang TT; Nguyen PH; Kim E; Thuong PT; Oh WK
Bioorg Med Chem Lett; 2012 Jun; 22(11):3688-92. PubMed ID: 22552195
[TBL] [Abstract][Full Text] [Related]
16. Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors.
Mooney CA; Johnson SA; 't Hart P; Quarles van Ufford L; de Haan CA; Moret EE; Martin NI
J Med Chem; 2014 Apr; 57(7):3154-60. PubMed ID: 24649802
[TBL] [Abstract][Full Text] [Related]
17. Exploitation of the catalytic site and 150 cavity for design of influenza A neuraminidase inhibitors.
Adabala PJ; LeGresley EB; Bance N; Niikura M; Pinto BM
J Org Chem; 2013 Nov; 78(21):10867-77. PubMed ID: 24090215
[TBL] [Abstract][Full Text] [Related]
18. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
Mitrasinovic PM
Biophys Chem; 2009 Mar; 140(1-3):35-8. PubMed ID: 19117662
[TBL] [Abstract][Full Text] [Related]
19. The elusive crystal structure of the neuraminidase inhibitor Tamiflu (oseltamivir phosphate): molecular details of action.
Naumov P; Yasuda N; Rabeh WM; Bernstein J
Chem Commun (Camb); 2013 Mar; 49(19):1948-50. PubMed ID: 23370708
[TBL] [Abstract][Full Text] [Related]
20. Serendipitous discovery of a potent influenza virus a neuraminidase inhibitor.
Mohan S; Kerry PS; Bance N; Niikura M; Pinto BM
Angew Chem Int Ed Engl; 2014 Jan; 53(4):1076-80. PubMed ID: 24339250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
